Nemes Rush Group LLC

Position in JNJ — Johnson & Johnson

CIK 1982273 NOVI, MI

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,212,096

+$1,401,937 QoQ

Shares Held

91,397

+2.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

2.11%

of 13F equity value

Holder Rank

#675

of 4,664 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Nemes Rush Group LLC holds $73,842,544 across 14 Drug Manufacturers - General names. JNJ ranks #1 (31.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	91,397	$23,212,096
2	MRK	Merck & Co., Inc.	175,548	$22,557,918
3	LLY	ELI LILLY & Co	15,575	$18,681,123
4	ABBV	AbbVie Inc.	15,922	$4,006,612
5	GILD	Gilead Sciences, Inc.	26,864	$3,393,997
6	BMY	Bristol Myers Squibb Co	27,548	$1,587,315
7	PFE	Pfizer Inc	12,129	$292,066
8	AMGN	Amgen Inc	155	$56,128

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,212,096	91,397	+2.4%	Shares	Sole	2026-08-14
2026-03-31	$21,810,159	89,225	-7.5%	Shares	Sole	2026-04-21
2025-12-31	$19,961,569	96,456	+1.4%	Shares	Sole	2026-02-11
2025-09-30	$17,638,819	95,129	+1.5%	Shares	Sole	2025-11-13
2025-06-30	$14,317,257	93,730	+51.5%	Shares	Sole	2025-08-12
2025-03-31	$10,262,013	61,879	+10.6%	Shares	Sole	2025-05-07
2024-12-31	$8,092,067	55,954	+14.6%	Shares	Sole	2025-02-12
2024-09-30	$7,915,010	48,840	-4.7%	Shares	Sole	2024-11-13
2024-06-30	$7,493,477	51,269	+4.4%	Shares	Sole	2024-08-15
2024-03-31	$7,766,812	49,098	-9.3%	Shares	Sole	2024-05-15
2023-12-31	$8,486,060	54,141	-6.9%	Shares	Sole	2024-02-09
2023-09-30	$9,061,535	58,180	+3.3%	Shares	Sole	2023-11-09
2023-06-30	$9,326,555	56,347	—	Shares	Sole	2023-08-02
No filing history on record for this holder in this stock.